Unveiling the Unknown: AI's Prediction on Alien Discovery
In this episode, we discuss how a new AI model is creating hypotheses about alien life and uniquely predicting potential discoverers. We examine the impact of such AI tools in shaping the future of sp...
2 Jan 202410min
Google Bard's Leap: Transforming Screenshots into Code
In this episode, we discuss the latest update to Google Bard, where it can now create apps from just image screenshots. We examine how this innovation might change the landscape of software developmen...
2 Jan 202411min
Actors vs. AI: The Strike Disrupting Hollywood
In this episode, we discuss the unprecedented strike in Hollywood, as the film industry grapples with the ethical challenges of AI cloning actors. We examine the impact of this strike on movie product...
2 Jan 20247min
Meta's Game Changer: Introducing the Advanced CM3leon AI
In this episode, we discuss Meta's latest innovation, CM3leon AI, touted as a state-of-the-art breakthrough. We examine its significance in the tech world and how it sets new benchmarks for AI develop...
2 Jan 20248min
AI Transforms Customer Service: A 90% Reduction in Jobs
In this episode, we discuss the significant transformation in the customer service sector caused by AI, leading to the elimination of 90% of jobs. We examine the implications for employees and the inc...
2 Jan 20249min
ChatGPT Faces Competition: Meta's New Paid AI Service
In this episode, we discuss Meta's strategic decision to introduce a paid AI service, positioning itself as a direct competitor to OpenAI's ChatGPT. We examine the potential impacts of this move on co...
2 Jan 20248min
OpenAI Joins Forces with AP: A New Era or The End of Journalism?
In this episode, we delve into the recent partnership between the Associated Press and OpenAI. We debate the impact of AI on journalistic integrity and practices, questioning if this is a progressive ...
2 Jan 202410min
Recursion's AI Boost: Nvidia's $50M Investment in Drug Discovery
In this episode, we discuss Nvidia's strategic move to invest $50 million into Recursion, a company at the forefront of AI-enabled drug discovery. We examine how Nvidia's technology and Recursion's AI...
2 Jan 20249min
